Undisclosed Tubulopathy Program

About Averoa

Averoa is a private, Paris-based biotech focused on the high-need nephrology sector, leveraging decades of industry experience from its founding team. The company is in a pre-revenue, early-stage development phase, building a pipeline to treat chronic kidney disease (CKD) and rare renal tubulopathies. With a leadership team that includes veterans from Advicenne and major pharma, Averoa combines deep clinical development expertise with a strategic regulatory vision to advance its programs.

Therapeutic Areas